ArisGlobal to Present at eRegulatory Summit on “Automation in Regulatory – Excited or Scared: a near reality or distant dream?”
MIAMI, FL. April 11, 2018 -- ArisGlobal, LLC, a global ...
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
MIAMI, FL. April 11, 2018 -- ArisGlobal, LLC, a global ...
Miami, Florida, April 4th, 2018– ArisGlobal, a leading provider of an integrated, cloud-based suite of products with unmatched capabilities in solving the real-world research and development needs of life sciences organizations, today announced the expansion of its global offices and appointment of three key executives to the company’s management team.
ArisGlobal, LLC, a global leader in providing cloud-based software solutions for the life sciences, will present at the World Drug Safety Congress Americas 2018 conference to be held in Philadelphia, PA from April 10-11, 2018, on the topic “Automation is transforming pharmacovigilance. Is your organization ready?”
ArisGlobal, a leading provider of integrated cloud-based software solutions for life sciences, announces LifeSphere Publishing and LifeSphere Analytics, new solutions that will integrate with LifeSphere RIMS™ and LifeSphere IDMP™ to offer the most complete, unified platform for regulatory affairs. LifeSphere Publishing delivers streamlined publishing capabilities and content management, and LifeSphere Analytics ensures all reports and analyses will comply with regulatory requirements.
Leading Indian CRO enters partnership with ArisGlobal to enhance its ...
ArisGlobal, a leading provider of integrated, cloud-based software solutions for life sciences, announced that Vivek Ahuja, Vice President, Global Pharmacovigilance at ArisGlobal, will present a session at the January 22nd closed-door “Lunch and Learn” series, held at the DIA Pharmacovigilance and Risk Management Conference, scheduled for January 23-25, 2018 in Washington, D.C. “How Automation Can Deliver the Holy Grail in Safety"
MIAMI, FLORIDA. January 11, 2018, 2017 -- ArisGlobal, a leading ...
Changing leadership will rapidly advance company’s focus on LifeSphere® cognitive ...
LifeSphere Safety MultiVigilance is the first pharmacovigilance solution (version 7.4.1.1-HF1) to have successfully completed E2B R3 testing with the XCOMP EudraVigilance system. Organizations using this same tested version should contact the European Medicines Agency and confirm that step 5b can be performed by themselves without the need for confirmation by the Agency.
ArisGlobal today announced that a top-five global life sciences company based in the U.S. selected ArisGlobal’s LifeSphere Safety cloud solution suite as its enterprise-level pharmacovigilance and drug safety software platform to enhance their capabilities to deliver health and wellness outcomes to waiting patients around the globe and across all business units: pharmaceutical, medical devices and consumer packaged goods.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved